Global vaccine market report
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
World Health Organization
Abstract
Description
16 p.
The "Global vaccine market report 2023" provides an overview of global vaccine market dynamics to support equitable access to safe, effective, quality and affordable vaccines through the WHO Market Information for Access (MI4A) initiative. Focusing on 2022 and comparing trends with previous years, the report analyses market size, regulatory capacity, manufacturing and supply, global distribution, regional supply security, and pricing and procurement. It examines changes in vaccine volumes and market value following the COVID-19 pandemic, the concentration of vaccine manufacturing, regional production capacity, procurement mechanisms, and vaccine pricing across income groups. The report highlights continued disparities in vaccine access and market structure despite improvements in immunization coverage and ongoing investments in regional manufacturing. It describes persistent challenges related to supply concentration, stock-outs, affordability, and unequal access to adult vaccination, while reviewing progress in regulatory strengthening and collaborative registration procedures. Building on the previous edition, the report reinforces WHO’s call for coordinated action by governments, industry and international partners to strengthen market preparedness, promote technology transfer and transparency, expand regional manufacturing capacity, and improve equitable and sustainable access to vaccines worldwide.
The "Global vaccine market report 2023" provides an overview of global vaccine market dynamics to support equitable access to safe, effective, quality and affordable vaccines through the WHO Market Information for Access (MI4A) initiative. Focusing on 2022 and comparing trends with previous years, the report analyses market size, regulatory capacity, manufacturing and supply, global distribution, regional supply security, and pricing and procurement. It examines changes in vaccine volumes and market value following the COVID-19 pandemic, the concentration of vaccine manufacturing, regional production capacity, procurement mechanisms, and vaccine pricing across income groups. The report highlights continued disparities in vaccine access and market structure despite improvements in immunization coverage and ongoing investments in regional manufacturing. It describes persistent challenges related to supply concentration, stock-outs, affordability, and unequal access to adult vaccination, while reviewing progress in regulatory strengthening and collaborative registration procedures. Building on the previous edition, the report reinforces WHO’s call for coordinated action by governments, industry and international partners to strengthen market preparedness, promote technology transfer and transparency, expand regional manufacturing capacity, and improve equitable and sustainable access to vaccines worldwide.